Evidence map›Paper›PMID 23299053›Full record

ReviewCurrent opinion in nephrology and hypertension2013

Does vitamin D modulate blood pressure?

Hector Tamez, Sahir Kalim, Ravi I Thadhani

Abstract readReview
In one paragraph

Review in Current opinion in nephrology and hypertension, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Vitamin D and cardiovascular diseases: A narrative review.Journal of family medicine and primary care · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Evaluation of Vitamin D Fractions in Obese Hypertensive Patients.International journal of environmental research and public health · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Vitamin D and regulation of vascular cell function.American journal of physiology. Heart and circulatory physiology · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hector TamezDivision of Nephrology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Sahir Kalim
Ravi I Thadhani

Funding

Redefining Vitamin D Deficiency: The Role of Bioavailable Vitamin DR01DK094486 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KARUMANCHI, S. ANANTH, THADHANI, RAVI · 2012 to 2018
$2.9M
Patient Oriented Studies of Vitamin D in Chronic Kidney DiseaseK24DK094872 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI THADHANI, RAVI · 2012 to 2016
$546k
NIDDK NIH HHS K24 DK094872
6 · The paper itself

Abstract

purpose of reviewBoth vitamin D deficiency and hypertension are highly prevalent. It is unclear whether vitamin D modulates blood pressure and therefore whether vitamin D testing and therapy should become part of routine hypertension prevention and management. This article provides an overview of the data, with special emphasis on the work published in the last 2 years. RECENT

findingsSeveral animal studies corroborate the strong effect of vitamin D on the renin-angiotensin-aldosterone axis. Small and large observational studies have found associations between vitamin D, increased blood pressure, and the risk of developing hypertension. In contrast, recent data from randomized trials are mixed. Two randomized trials with approximately 1 year of follow-up detected no association between vitamin D treatment and blood pressure, whereas another study of active vitamin D reported a 9-mmHg decrease in systolic blood pressure. Meta-analyses have linked vitamin D levels with blood pressure, but the effect of vitamin D administration on blood pressure remains controversial. SUMMARY: Vitamin D deficiency is asociated with high blood pressure in observational studies. This effect is thought to be partly mediated through regulation of the renin-angiotensin-aldosterone axis. However, randomized clinical trials and their meta-analyses have yielded inconclusive results. Large randomized trials focusing on patients with severe vitamin D deficiency and hypertension are needed before vitamin D can be recommended for the prevention or treatment of hypertension.

Indexed as

Blood PressureAnimalsDietary SupplementsHumansHypertensionRenin-Angiotensin SystemTreatment OutcomeVitamin DVitamin D DeficiencyVitaminsVitamin DVitamins

Identifiers

PMID23299053
PMCPMC3984388

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.